Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy With Erythropoietin: A Phase III Randomised Placebo Controlled Multicentre Clinical Trial

NCT03079167 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT03079167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy With Erythropoietin: A Phase III Randomised Placebo Controlled Multicentre Clinical Trial
Lead sponsor
University of Sydney
Phase
Phase 3
Overall status
Completed
Start date
May 14, 2016
Completion date
April 30, 2024
Enrollment
313 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy